C. White

发表

Deletion Analysis of a Defective Interfering Semliki Forest Virus RNA Genome Defines a Region in the nsP2 Sequence That Is Required for Efficient Packaging of the Genome into Virus Particles

C. White, M. Thomson, N. Dimmock, 1998, Journal of Virology.

Complete pathway for protein disulfide bond formation encoded by poxviruses

E. Koonin, B. Moss, C. White, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Expression of the vaccinia virus A2.5L redox protein is required for virion morphogenesis.

E. Koonin, B. Moss, J. Granek, 2002, Virology.

Radiation-Mediated Up-Regulation of Gene Expression from Replication-Defective Adenoviral Vectors: Implications for Sodium Iodide Symporter Gene Therapy

A. Melcher, R. Vile, H. Pandha, 2008, Clinical Cancer Research.

The protein activator of protein kinase R, PACT/RAX, negatively regulates protein kinase R during mouse anterior pituitary development

P. Kessler, C. White, G. Sen, 2015, The FEBS journal.

Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo

K. Twigger, S. Bhide, A. Melcher, 2008, Gene Therapy.

Phosphatidylinositol 3-Kinase Signaling Delays Sendai Virus-Induced Apoptosis by Preventing XIAP Degradation

C. White, G. Sen, S. Chattopadhyay, 2011, Journal of Virology.

Enlarged spleens without enlarged lymph nodes in tlr3-/- pkr-/- mice.

B. Williams, C. White, M. Whitmore, 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Missense Mutation in the Second RNA Binding Domain Reveals a Role for Prkra (PACT/RAX) during Skull Development

Y. Hérault, C. Chevalier, C. White, 2011, PloS one.

The role of PACT in mediating gene induction, PKR activation, and apoptosis in response to diverse stimuli.

B. Williams, G. Peters, J. Marques, 2008, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

The genomic sequence of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo.

C. White, N. Dimmock, M. Thomson, 1998, Virology.

Microvascular free tissue transfer for gene delivery: in vivo evaluation of different routes of plasmid and adenoviral delivery

C. Porter, A. Melcher, H. Pandha, 2009, Gene Therapy.

Phosphatidylinositol 3-Kinase Signaling Delays Sendai Virus-Induced Apoptosis by Preventing XIAP Degradation (cid:1)

C. White, G. Sen, S. Chattopadhyay, 2011 .

A Glutaredoxin, Encoded by the G4L Gene of Vaccinia Virus, Is Essential for Virion Morphogenesis

B. Moss, C. White, A. Weisberg, 2000, Journal of Virology.

Therapeutic effect of sodium iodide symporter gene therapy combined with external beam radiotherapy and targeted drugs that inhibit DNA repair.

K. Syrigos, S. Bhide, A. Melcher, 2010, Molecular Therapy.

Vaccinia Virus G4L Glutaredoxin Is an Essential Intermediate of a Cytoplasmic Disulfide Bond Pathway Required for Virion Assembly

B. Moss, C. White, T. Senkevich, 2002, Journal of Virology.

Reovirus and other oncolytic viruses for the targeted treatment of cancer

K. Twigger, K. Harrington, J. Bono, 2006, Targeted Oncology.

Inhibition of repair of radiation-induced DNA damage enhances gene expression from replication-defective adenoviral vectors.

A. Melcher, R. Vile, H. Pandha, 2008, Cancer research.

Combining radiation and cancer gene therapy: a potential marriage of physical and biological targeting?

A. Melcher, K. Harrington, C. White, 2007, Current cancer drug targets.

C-Rel Regulates Interleukin 12 P70 Expression in Cd8+ Dendritic Cells by Specifically Inducing p35 Gene Transcription

Meredith O'Keeffe, S. Gerondakis, R. Grumont, 2001, The Journal of experimental medicine.

Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial

M. Coffey, K. Twigger, F. Errington, 2008, Gene Therapy.

Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy

M. Coffey, K. Twigger, S. Bhide, 2008, Clinical Cancer Research.

cells by neutralizing Bim via distinct mechanisms B1 and c-Rel cooperate to promote the survival of TLR4-activated B κ NF-

A. Strasser, R. Grumont, C. White, 2012 .

NF-kappaB1 and c-Rel cooperate to promote the survival of TLR4-activated B cells by neutralizing Bim via distinct mechanisms.

A. Strasser, S. Gerondakis, R. Grumont, 2008, Blood.

The pharmacologic basis for the efficacy of high-dose Ara-C and sequential asparaginase in adult acute myelogenous leukemia.

C. White, R. Capizzi, Robert L. Capizzi, 1988, The Yale journal of biology and medicine.

Tissue-Specific and Inducer-Specific Differential Induction of ISG56 and ISG54 in Mice

B. Williams, C. White, G. Sen, 2007, Journal of Virology.

Novel Characteristics of the Function and Induction of Murine p56 Family Proteins

C. White, G. Sen, Volker Fensterl, 2008, Journal of Virology.

Interferon Regulatory Factor 8 (IRF8) Impairs Induction of Interferon Induced with Tetratricopeptide Repeat Motif (IFIT) Gene Family Members*

K. Ozato, P. Kessler, C. White, 2016, The Journal of Biological Chemistry.

Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma

M. Coffey, K. Twigger, F. Errington, 2008, Gene Therapy.

A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer

M. Coffey, K. Twigger, A. Melcher, 2008, Clinical Cancer Research.

Dendritic Cells by Specifically Inducing p 35 Gene Transcription

S. Gerondakis, R. Grumont, C. White, 2001 .

Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene.

Christiana N. Fogg, Christiana Fogg, L. Pannell, 2005, Virology.

A viral member of the ERV1/ALR protein family participates in a cytoplasmic pathway of disulfide bond formation.

E. Koonin, B. Moss, C. White, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin–paclitaxel doublet chemotherapy

G. Nuovo, M. Coffey, K. Twigger, 2012, Gene Therapy.

Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers

M. Coffey, K. Twigger, V. Roulstone, 2010, Clinical Cancer Research.

APhase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer

M. Coffey, K. Twigger, R. Vile, 2008 .

Interferons and Antiviral Action

C. White, G. Sen, 2009 .

The Protein Kinase Double-Stranded RNA-Dependent (PKR) Enhances Protection against Disease Cause by a Non-Viral Pathogen

C. White, G. Sen, C. Subauste, 2013, PLoS pathogens.

The kinase activity of PKR represses inflammasome activity

B. Williams, C. White, P. Faber, 2016, Cell Research.

Antiviral antibody responses to systemic administration of an oncolytic RNA virus: the impact of standard concomitant anticancer chemotherapies

K. Twigger, V. Roulstone, R. Vile, 2021, Journal for ImmunoTherapy of Cancer.